» Articles » PMID: 24130900

Inhibition of SPLA₂-IIA Prevents LPS-induced Neuroinflammation by Suppressing ERK1/2-cPLA₂α Pathway in Mice Cerebral Cortex

Overview
Journal PLoS One
Date 2013 Oct 17
PMID 24130900
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Neuroinflammation is involved in various central nervous system (CNS) disorders, including brain infections, ischemia, trauma, stroke, and degenerative CNS diseases. In the CNS inflammation, secretory phospholipase A₂-IIA (sPLA₂-IIA) acts as a mediator, resulting in the generation of the precursors of pro-inflammatory lipid mediators, such as prostaglandins (PGs) and leukotrienes (LTs). However, the role of sPLA₂-IIA in neuroinflammation is more complicated and remains unclear yet. In the present study, we investigated the effect of sPLA₂-IIA inhibition by specific inhibitor SC-215 on the inflammation in LPS-induced mice cerebral cortex and primary astrocytes. Our results showed that the inhibition of sPLA₂-IIA alleviated the release of PGE₂ by suppressing the activation of ERK1/2, cPLA₂α, COX-2 and mPGES-1. These findings demonstrated that sPLA₂-IIA showed the potential to regulate the neuroinflammation in vivo and in vitro, indicating that sPLA₂-IIA might be a novel target for the treatment of acute neuroinflammation.

Citing Articles

High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome.

Ahmad N, Tan T, Tajul Arifin K, Wan Ngah W, Mohd Yusof Y PLoS One. 2020; 15(3):e0230285.

PMID: 32160261 PMC: 7065791. DOI: 10.1371/journal.pone.0230285.


SIRT2 Plays Significant Roles in Lipopolysaccharides-Induced Neuroinflammation and Brain Injury in Mice.

Wang B, Zhang Y, Cao W, Wei X, Chen J, Ying W Neurochem Res. 2016; 41(9):2490-500.

PMID: 27350577 DOI: 10.1007/s11064-016-1981-2.


Role of cytosolic phospholipase A2 in oxidative and inflammatory signaling pathways in different cell types in the central nervous system.

Sun G, Chuang D, Zong Y, Jiang J, Lee J, Gu Z Mol Neurobiol. 2014; 50(1):6-14.

PMID: 24573693 PMC: 4147031. DOI: 10.1007/s12035-014-8662-4.

References
1.
Murakami M, Kambe T, Shimbara S, Kudo I . Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J Biol Chem. 1999; 274(5):3103-15. DOI: 10.1074/jbc.274.5.3103. View

2.
Johnson R, Gheusi G, Segreti S, Dantzer R, Kelley K . C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Res. 1997; 752(1-2):219-26. DOI: 10.1016/s0006-8993(96)01454-0. View

3.
Teismann P, Tieu K, Cohen O, Choi D, Wu D, Marks D . Pathogenic role of glial cells in Parkinson's disease. Mov Disord. 2003; 18(2):121-9. DOI: 10.1002/mds.10332. View

4.
Murakami M, Kudo I . Phospholipase A2. J Biochem. 2002; 131(3):285-92. DOI: 10.1093/oxfordjournals.jbchem.a003101. View

5.
Tian W, Wijewickrama G, Kim J, Das S, Tun M, Gokhale N . Mechanism of regulation of group IVA phospholipase A2 activity by Ser727 phosphorylation. J Biol Chem. 2007; 283(7):3960-71. DOI: 10.1074/jbc.M707345200. View